Publikationer i Christine Dyragers grupp

14. Specific Imaging of Intracellular Lipid Droplets using a Benzothiadiazole Derivative with Solvatochromic Properties. Appelqvist, H.; Stranius, K.; Börjesson, K.; Nilsson, K.P.; Dyrager, C.* Bioconjugate Chem. 2017, 28, 1363-1370.

13. Synthesis and Evaluation of Benzothiazole-triazole and Benzothiadiazole-triazole Derivatives as Potential Molecular Probes for Amyloid-beta. Dyrager, C*.; Vieira, R. P.; Nyström, S.; Nilsson, P. R.; Storr, T. New. J. Chem. 2017, 41, 1566-1573.

12. Multi-target-Directed Phenol-Triazole Ligands as Therapeutic Agents for Alzheimer’s Disease. Jones, M.; Mathieu, E.; Dyrager, C.; Faissner, S.; Vaillancourt, X.; Korshavn, K.; Lim, M.; Ramamoorty, A.; Yong, V.W.; Tsutsui, S.; Stys, P.; Storr, T.* Chem. Sci. 2017, 8, 5636-5643.

11. Multifunctional Quinoline-Triazole Derivatives as Potential Modulators of Aβ Peptide Aggregation. Jones, M. R.; Dyrager, C.; Hoarau, M.; Korshavn, K. J.; Lim, M.; Ramamoorthy, A.; Storr, T.* Inorg. Biochem. 2016. 158, 131-138.

10. Chroman-4-on and Chromone Based Somatostatin b-Turn Mimetics. Fridén-Saxin, M.; Seifert, T.; Malo, M.; Da Silva-Andersson, K.; Pemberton, N.; Dyrager, C.; Friberg, A.; Dahlén, K.; Wallén, E. A. A.; Grøtli, M.; Luthman, K.* Eur. J. Med. Chem. 2016, 114, 59-64.

9. Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis. Karlsson, E; Magić, I; Bostner, J; Dyrager, C; Lysholm, F; Hallbeck, A-L; Stål, O; Lundström, P.* PLoS ONE 2015, (DOI:1371/journal.pone.0145013, published Dec 23, 2015).

8. Towards the Development of Chromone-based MEK1/2 Modulators. Namro Redwan, I.; Dyrager, C; Solano, C; Fernández de Trocóniz, G: Voisin, L; Bliman, D, Meloche, S; Grøtli, M.* Eur. J. Med. Chem. 2014, 85, 127-138.

7. 8-Hydroxyquinoline Schiff-base Compounds as Antioxidants and Modulators of Copper-mediated Ab Peptide Aggregation. Gomes, L. M. F; Vieira, R. P; Jones, M. R; Wang, M. C. P; Dyrager, C; Souza-Fagundes, E. M; Da Silva, J. G; Storr, T; Beraldo, H. Inorg. Biochem. 2014, 139, 106-116.

6. Alternative Cytotoxic Effects of the Postulated IGF-IR Inhibitor Picropodophillin in Vitro. Wu, X; Sooman, L; Wickström, M; Fryknäs, M; Dyrager, C; Lennartsson, J; Gullbo.* J. Cancer. Ther. 2013, 12, 1526-1536.

5. Design, Synthesis and Biological Evaluation of Chromone-based p38 MAP Kinase Inhibitors. Dyrager, C.; Nilsson-Möllers, L.; Karlsson-Kjäll, L.; Alao, J. P.; Dinér, P.; Wallnér, F. K.; Sunnerhagen, P.; Grøtli, M.* J. Med. Chem. 2011, 54, 7427-7431.

4. Inhibitors and Promoters of Tubulin Polymerization: Synthesis and Biological Evaluation of Chalcones and Related Dienones as Potential Anticancer Agents. Dyrager, C.; Wickström, M.; Fridén-Saxin, M.; Friberg, A.; Dahlén, K.; Wallén, E. A. A.; Gullbo, J.; Grøtli, M.; Luthman, K.* J. Bioorg. Med. Chem. 2011, 19, 2659-2665.

3. Synthesis of 2-Alkyl-Substituted Chromone Derivatives Using Microwave Irradiation. Fridén-Saxin, M.; Pemberton, N.; Da Silva-Andersson, K.; Dyrager, C.; Friberg, A.; Grøtli, M.; Luthman, K.* J. Org. Chem. 2009, 74, 2755-2759.

2. Synthesis and Photophysical Characterisation of Fluorescent 8-(1H-1,2,3-Triazol-4-yl)adenosine Derivatives. Dyrager, C.; Börjesson, K.; Dinér, P.; Elf, A.; Albinsson, B.; Wilhelmsson, M. L.; Grøtli, M.* Eur. J. Org. Chem. 2009, 10, 1515-1521.

1. 2,6,8-Trisubstituted 3-Hydroxychromone Derivatives as Fluorophores for Live-Cell Imaging. Dyrager, C.; Friberg, A.; Dahlén, K.; Fridén-Saxin, M.; Börjesson, K.; Wilhelmsson, M.; Smed, M.; Grøtli, M.; Luthman, K.* Chem. Eur. J. 2009, 15, 9417-9423